Neonc Technologies Holdings, Stock Cash Flow From Operations
| NTHI Stock | 4.97 0.02 0.40% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess NeOnc Technologies' long-term financial health and intrinsic value.
NeOnc | Cash Flow From Operations | Build AI portfolio with NeOnc Stock |
NeOnc Technologies Holdings, Company Cash Flow From Operations Analysis
NeOnc Technologies' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current NeOnc Technologies Cash Flow From Operations | (4.21 M) |
Most of NeOnc Technologies' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeOnc Technologies Holdings, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NeOnc Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for NeOnc Technologies is extremely important. It helps to project a fair market value of NeOnc Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since NeOnc Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NeOnc Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NeOnc Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, NeOnc Technologies Holdings, has (4.21 Million) in Cash Flow From Operations. This is 100.8% lower than that of the Pharmaceuticals sector and 106.74% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.43% higher than that of the company.
NeOnc Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeOnc Technologies' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeOnc Technologies could also be used in its relative valuation, which is a method of valuing NeOnc Technologies by comparing valuation metrics of similar companies.NeOnc Technologies is currently under evaluation in cash flow from operations category among its peers.
NeOnc Fundamentals
| Operating Margin | (939.66) % | ||||
| Current Valuation | 83.68 M | ||||
| Shares Outstanding | 19.03 M | ||||
| Shares Owned By Insiders | 53.00 % | ||||
| Shares Owned By Institutions | 0.30 % | ||||
| Number Of Shares Shorted | 225.86 K | ||||
| Price To Sales | 1,135 X | ||||
| Revenue | 83 K | ||||
| Gross Profit | 79.99 K | ||||
| EBITDA | (9.1 M) | ||||
| Net Income | (11.9 M) | ||||
| Total Debt | 24.72 K | ||||
| Book Value Per Share | (0.51) X | ||||
| Cash Flow From Operations | (4.21 M) | ||||
| Short Ratio | 0.45 X | ||||
| Earnings Per Share | (2.47) X | ||||
| Market Capitalization | 90.76 M | ||||
| Total Asset | 3.42 M | ||||
| Retained Earnings | (50.61 M) | ||||
| Working Capital | (6.73 M) | ||||
| Net Asset | 3.42 M |
About NeOnc Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeOnc Technologies Holdings,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeOnc Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeOnc Technologies Holdings, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out NeOnc Technologies Piotroski F Score and NeOnc Technologies Altman Z Score analysis. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeOnc Technologies. If investors know NeOnc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeOnc Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NeOnc Technologies is measured differently than its book value, which is the value of NeOnc that is recorded on the company's balance sheet. Investors also form their own opinion of NeOnc Technologies' value that differs from its market value or its book value, called intrinsic value, which is NeOnc Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeOnc Technologies' market value can be influenced by many factors that don't directly affect NeOnc Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeOnc Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeOnc Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeOnc Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.